GlaxoSmithKline
GSK
#294
Rank
NZ$115.55 B
Marketcap
$56.64
Share price
-0.10%
Change (1 day)
-2.57%
Change (1 year)

GlaxoSmithKline (GSK) - Cash on Hand

Cash on Hand as of September 2024 : NZ$7.30 Billion

According to GlaxoSmithKline's latest financial reports the company has NZ$7.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

GlaxoSmithKline - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$10.05 B-31.25%
2022-12-31NZ$14.62 B79.02%
2021-12-31NZ$8.17 B-29.89%
2020-12-31NZ$11.65 B30.54%
2019-12-31NZ$8.92 B19.21%
2018-12-31NZ$7.49 B0.64%
2017-12-31NZ$7.44 B-16.2%
2016-12-31NZ$8.88 B-30.53%
2015-12-31NZ$12.78 B46%
2014-12-31NZ$8.75 B-22.1%
2013-12-31NZ$11.24 B34.14%
2012-12-31NZ$8.37 B-28.66%
2011-12-31NZ$11.74 B-5.94%
2010-12-31NZ$12.48 B-19.26%
2009-12-31NZ$15.46 B-10.86%
2008-12-31NZ$17.35 B47.46%
2007-12-31NZ$11.76 B39.25%
2006-12-31NZ$8.44 B-36%
2005-12-31NZ$13.20 B23.37%
2004-12-31NZ$10.70 B12.7%
2003-12-31NZ$9.49 B25.53%
2002-12-31NZ$7.56 B-6.68%
2001-12-31NZ$8.10 B-33%
2000-12-31NZ$12.09 B99.02%
1999-12-31NZ$6.07 B2.2%
1998-12-31NZ$5.94 B26.42%
1997-12-31NZ$4.70 B53.82%
1996-12-31NZ$3.05 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$12.02 B 64.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$16.91 B 131.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$24.80 B 239.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.83 B 226.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$12.38 B 69.45%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$5.64 B-22.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$1.25 B-82.89%๐Ÿ‡บ๐Ÿ‡ธ USA